Summary & Overview
HCPCS Level II J7502: Cyclosporine, Oral, 100 mg
HCPCS Level II code J7502 identifies 100 mg oral cyclosporine, a systemic immunosuppressant used in multiple clinical settings including transplant medicine and certain autoimmune conditions. Nationally, drug billing codes like J7502 are important for pharmacy reimbursement, benefit design, prior authorization workflows, and cost management across commercial insurers and Medicare. The analysis covers common payers: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find a concise overview of what J7502 represents clinically and operationally, plus national payer coverage context. The publication outlines typical sites of service, common billing considerations, and the types of benchmarks and policy updates relevant to oral specialty medications. It also summarizes what to expect in payer coverage policies, prior authorization prevalence, and potential utilization management tools applied to oral immunosuppressants. Where specific input data is missing, the report notes "Data not available in the input."
Billing Code Overview
HCPCS Level II code J7502 represents Cyclosporine, oral, 100 mg. This code denotes a prescription oral immunosuppressant formulation of cyclosporine supplied in 100 mg dosing units.
-
Service type: Pharmacy-dispensed oral medication
-
Typical site of service: Outpatient pharmacy or retail pharmacy for patient self-administration
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult organ transplant recipient or a patient with severe autoimmune disease who requires chronic systemic immunosuppression. The patient presents for outpatient medication management with an established hematology/transplant or rheumatology clinic. The clinician reviews prior medication history, therapeutic drug monitoring (trough) levels, renal and hepatic function, and interacts with a specialty pharmacy. A prescription for oral cyclosporine J7502 (100 mg capsules) is written or renewed. The clinical workflow includes medication reconciliation, documentation of indication (for example, prevention of graft rejection or control of refractory autoimmune disease), consent for immunosuppressive therapy risks, ordering baseline and follow-up laboratory tests (serum creatinine, liver enzymes, trough cyclosporine level), and coordination of dispensing through outpatient pharmacy or specialty supplier. Typical site of service is outpatient clinic, specialty pharmacy dispensing, or home administration with outpatient follow-up. Common clinical monitoring visits occur every 1–3 months or more frequently during dose adjustment or when interacting medications are started or stopped.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier (unmodified) | Use when no modifier is required and the service is reported in the usual manner |